SUMOylation Regulates Insulin Exocytosis Downstream of Secretory Granule Docking in Rodents and Humans
Open accessAbstract
OBJECTIVE: The reversible attachment of small ubiquitin-like modifier (SUMO) proteins controls target localization and function. We examined an acute role for the SUMOylation pathway in downstream events mediating insulin secretion. RESEARCH DESIGN AND METHODS: We studied islets and β-cells from mice and human donors, as well as INS-1 832/13 cells. Insulin secretion, intracellular Ca2+, and β-cell exocytosis were monitored after manipulation of the SUMOylation machinery. Granule localization was imaged by total internal reflection fluorescence and electron microscopy; immunoprecipitation and Western blotting were used to examine the soluble NSF attachment receptor (SNARE) complex formation and SUMO1 interaction with synaptotagmin VII. RESULTS: SUMO1 impairs glucose-stimulated insulin secretion by blunting the β-cell exocytotic response to Ca2+. The effect of SUMO1 to impair insulin secretion and β-cell exocytosis is rapid and does not require altered gene expression or insulin content, is downstream of granule docking at the plasma membrane, and is dependent on SUMO-conjugation because the deSUMOylating enzyme, sentrin/SUMO-specific protease (SENP)-1, rescues exocytosis. SUMO1 coimmunoprecipitates with the Ca2+ sensor synaptotagmin VII, and this is transiently lost upon glucose stimulation. SENP1 overexpression also disrupts the association of SUMO1 with synaptotagmin VII and mimics the effect of glucose to enhance exocytosis. Conversely, SENP1 knockdown impairs exocytosis at stimulatory glucose levels and blunts glucose-dependent insulin secretion from mouse and human islets. CONCLUSIONS: SUMOylation acutely regulates insulin secretion by the direct and reversible inhibition of β-cell exocytosis in response to intracellular Ca2+ elevation. The SUMO protease, SENP1, is required for glucose-dependent insulin secretion.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The amplifying effect of glucose via desumoylation of synaptotagmin-7 can occur without physical translocation of secretory granules.
“Notably, the amplifying effect of glucose (via desumoylation of synaptotagmin-7) can occur without physical translocation of secretory granules (136).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [136]
The Results (‘SUMOylation increases granule docking and SNARE complex formation’; page unavailable) say SUMO1 does not inhibit secretion by reducing granule recruitment or docking, placing its effect downstream of docking. The Discussion reports that glucose transiently disrupts the SUMO1/synaptotagmin VII interaction and that SENP1 mimics glucose’s enhancement of exocytosis, but says the underlying mechanism remains to be elucidated. Thus the paper supports an effect downstream of granule translocation, not the definite claim that glucose acts via desumoylation of synaptotagmin-7. (LLM, conf=0.84)
Experimental — accuracy not yet measuredGlucose increases exocytosis by NADPH-dependent activation of the deSUMOylating enzyme SENP-1.
“Glucose increases exocytosis by NADPH-dependent activation of the deSUMOylating enzyme SENP-1 (136).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [136]
The Results section reports that glucose enhances β-cell exocytosis and that SENP1 knockdown prevents this enhancement. The Discussion says SENP1 mimics glucose’s effect, but explicitly states that the underlying mechanism remains to be elucidated. Our copy does not establish NADPH-dependent activation of SENP1. (LLM, conf=0.90)
Experimental — accuracy not yet measuredIn both mouse and human β-cells, the modulation of exocytosis by glucose involves the reversible attachment of SUMO-1 to synaptotagmin-7.
“In both mouse and human β-cells there is evidence that this modulation involves the reversible attachment of small ubiquitin-like modifier protein 1 (SUMO-1) to synaptotagmin-7.”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [136]
The Results section, “SUMO1 interacts dynamically with synaptotagmin VII” (page not provided), reports a SUMOylation-dependent interaction in rodent cells and human islets that is transiently disrupted by glucose. But the Discussion (page not provided) explicitly says further work is needed to determine whether SUMO1 is attached directly to synaptotagmin VII or to a binding partner. The evidence supports a reversible association, not the specified attachment. (LLM, conf=0.89)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
No references could be resolved yet.
Research works printed but not linked: 43
- [1]Hilgarth RS Murphy LA Skaggs HS Wilkerson DC Xing H Sarge KD Regulation and function of SUMO modification. J Biol Chem 2004; 279: 53899– 53902 15448161
- [2]Hay RT SUMO: a history of modification. Mol Cell 2005; 18: 1– 12 15808504
- [3]Müller S Ledl A Schmidt D SUMO: a regulator of gene expression and genome integrity. Oncogene 2004; 23: 1998– 2008 15021887
- [4]Verger A Perdomo J Crossley M Modification with SUMO: a role in transcriptional regulation. EMBO Rep 2003; 4: 137– 142 12612601 PMC1315836
- [5]Seeler JS Dejean A Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol 2003; 4: 690– 699 14506472
- [6]Ehninger A Mziaut H Solimena M Emerging role of SUMO in pancreatic beta-cells. Horm Metab Res 2007; 39: 658– 664 17846973
- [7]Shao C Cobb MH Sumoylation regulates the transcriptional activity of MafA in pancreatic beta cells. J Biol Chem 2009; 284: 3117– 3124 19029092 PMC2631948
- [8]Kishi A Nakamura T Nishio Y Maegawa H Kashiwagi A Sumoylation of Pdx1 is associated with its nuclear localization and insulin gene activation. Am J Physiol Endocrinol Metab 2003; 284: E830– E840 12488243
- [9]Trajkovski M Mziaut H Altkrüger A Nuclear translocation of an ICA512 cytosolic fragment couples granule exocytosis and insulin expression in β-cells. J Cell Biol 2004; 167: 1063– 1074 15596545 PMC2172607
- [10]Johnson ES Protein modification by SUMO. Annu Rev Biochem 2004; 73: 355– 382 15189146
- [11]Rajan S Plant LD Rabin ML Butler MH Goldstein SA Sumoylation silences the plasma membrane leak K+ channel K2P1. Cell 2005; 121: 37– 47 15820677
- [12]Benson MD Li QJ Kieckhafer K SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5. Proc Natl Acad Sci USA 2007; 104: 1805– 1810 17261810 PMC1794304
- [13]Dai XQ Kolic J Marchi P Sipione S Macdonald PE SUMOylation regulates Kv2.1 and modulates pancreatic β-cell excitability. J Cell Sci 2009; 122: 775– 779 19223394
- [14]Plant LD Dementieva IS Kollewe A Olikara S Marks JD Goldstein SA One SUMO is sufficient to silence the dimeric potassium channel K2P1. Proc Natl Acad Sci USA 2010; 107: 10743– 10748 20498050 PMC2890841
- [15]Kruse M Schulze-Bahr E Corfield V Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. J Clin Invest 2009; 119: 2737– 2744 19726882 PMC2735920
- [16]Martin S Nishimune A Mellor JR Henley JM SUMOylation regulates kainate-receptor-mediated synaptic transmission. Nature 2007; 447: 321– 325 17486098 PMC3310901
- [17]Feligioni M Nishimune A Henley JM Protein SUMOylation modulates calcium influx and glutamate release from presynaptic terminals. Eur J Neurosci 2009; 29: 1348– 1356 19344328 PMC3309032
- [18]Jewell JL Oh E Thurmond DC Exocytosis mechanisms underlying insulin release and glucose uptake: conserved roles for Munc18c and syntaxin 4. Am J Physiol Regul Integr Comp Physiol 2010; 298: R517– R531 20053958 PMC2838661
- [19]Rorsman P Renström E Insulin granule dynamics in pancreatic beta cells. Diabetologia 2003; 46: 1029– 1045 12879249
- [20]Rutter GA Hill EV Insulin vesicle release: walk, kiss, pause...then run. Physiology (Bethesda) 2006; 21: 189– 196 16714477
- [21]Barg S Ma X Eliasson L Fast exocytosis with few Ca(2+) channels in insulin-secreting mouse pancreatic B cells. Biophys J 2001; 81: 3308– 3323 11720994 PMC1301788
- [22]Wiser O Trus M Hernández A The voltage sensitive Lc-type Ca2+ channel is functionally coupled to the exocytotic machinery. Proc Natl Acad Sci USA 1999; 96: 248– 253 9874804 PMC15125
- [23]Gustavsson N Lao Y Maximov A Impaired insulin secretion and glucose intolerance in synaptotagmin-7 null mutant mice. Proc Natl Acad Sci USA 2008; 105: 3992– 3997 18308938 PMC2268794
- [24]Gauthier BR Wollheim CB Synaptotagmins bind calcium to release insulin. Am J Physiol Endocrinol Metab 2008; 295: E1279– E1286 18713958
- [25]Harder Z Zunino R McBride H Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission. Curr Biol 2004; 14: 340– 345 14972687
- [26]Pigeau GM Kolic J Ball BJ Insulin granule recruitment and exocytosis is dependent on p110γ in insulinoma and human β-cells. Diabetes 2009; 58: 2084– 2092 19549714 PMC2731529
- [27]Göpel SO Kanno T Barg S Weng XG Gromada J Rorsman P Regulation of glucagon release in mouse cells by KATP channels and inactivation of TTX-sensitive Na+ channels. J Physiol 2000; 528: 509– 520 11060128 PMC2270147
- [28]MacDonald PE Ha XF Wang J Members of the Kv1 and Kv2 voltage-dependent K(+) channel families regulate insulin secretion. Mol Endocrinol 2001; 15: 1423– 1435 11463864
- [29]Roe MW Worley JF 3rd Mittal AA Expression and function of pancreatic beta-cell delayed rectifier K+ channels. Role in stimulus-secretion coupling. J Biol Chem 1996; 271: 32241– 32246 8943282
- [30]Südhof TC Rothman JE Membrane fusion: grappling with SNARE and SM proteins. Science 2009; 323: 474– 477 19164740 PMC3736821
- [31]Atlas D Functional and physical coupling of voltage-sensitive calcium channels with exocytotic proteins: ramifications for the secretion mechanism. J Neurochem 2001; 77: 972– 985 11359862
- [32]Hoppa MB Collins S Ramracheya R Chronic palmitate exposure inhibits insulin secretion by dissociation of Ca(2+) channels from secretory granules. Cell Metab 2009; 10: 455– 465 19945403 PMC2814048
- [33]Kanno T Ma X Barg S Large dense-core vesicle exocytosis in pancreatic beta-cells monitored by capacitance measurements. Methods 2004; 33: 302– 311 15183179
- [34]Ren J Gao X Jin C Systematic study of protein sumoylation: development of a site-specific predictor of SUMOsp 2.0. Proteomics 2009; 9: 3409– 3412 29658196
- [35]Iezzi M Kouri G Fukuda M Wollheim CB Synaptotagmin V and IX isoforms control Ca2+-dependent insulin exocytosis. J Cell Sci 2004; 117: 3119– 3127 15190121
- [36]Iezzi M Eliasson L Fukuda M Wollheim CB Adenovirus-mediated silencing of synaptotagmin 9 inhibits Ca2+-dependent insulin secretion in islets. FEBS Lett 2005; 579: 5241– 5246 16165130
- [37]Braschi E Zunino R McBride HM MAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fission. EMBO Rep 2009; 10: 748– 754 19407830 PMC2727426
- [38]Feliciangeli S Bendahhou S Sandoz G Does sumoylation control K2P1/TWIK1 background K+ channels? Cell 2007; 130: 563– 569 17693262
- [39]Jacobson DA Kuznetsov A Lopez JP Kash S Ammälä CE Philipson LH Kv2.1 ablation alters glucose-induced islet electrical activity, enhancing insulin secretion. Cell Metab 2007; 6: 229– 235 17767909 PMC2699758
- [40]Zunino R Schauss A Rippstein P Andrade-Navarro M McBride HM The SUMO protease SENP5 is required to maintain mitochondrial morphology and function. J Cell Sci 2007; 120: 1178– 1188 17341580
- [41]Yeh ET SUMOylation and De-SUMOylation: wrestling with life’s processes. J Biol Chem 2009; 284: 8223– 8227 19008217 PMC2659178
- [42]Kawaguchi M Minami K Nagashima K Seino S Essential role of ubiquitin-proteasome system in normal regulation of insulin secretion. J Biol Chem 2006; 281: 13015– 13020 16543239
- [43]Gauthier BR Duhamel DL Iezzi M Synaptotagmin VII splice variants alpha, beta, and delta are expressed in pancreatic beta-cells and regulate insulin exocytosis. FASEB J 2008; 22: 194– 206 17709608
Cited by
Sorted by citations
Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men
Rorsman, P., & Ashcroft, F. M. (2018) · Physiological Reviews · doi:10.1152/physrev.00008.2017 · Cited by 793 · see citing works
Regulation of Insulin Secretion in Human Pancreatic Islets
Rorsman, P., & Braun, M. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183754 · Cited by 599 · see citing works
Glucagon secretion from pancreatic α-cells
Briant, L., Salehi, A., Vergari, E., Zhang, Q., & Rorsman, P. (2016) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2016.1156789 · Cited by 109 · see citing works
- Authors
- Dai, X.-Q., Plummer, G., Casimir, M., Kang, Y., Hajmrle, C., Gaisano, H. Y., Manning Fox, J. E., & MacDonald, P. E.
- Affiliations
- University of Alberta (CA)
- University of Toronto (CA)
- Department of Pharmacology and Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada
- Corresponding author
- MacDonald, Patrick E.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-02-21
- Volume
- 60
- Issue
- 3
- Pages
- 838-847
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3046844
- OpenAlex
- W2140346195
- Cited by
- 92
- References
- 0
- Citations by year
- 2025: 3 · 2024: 5 · 2023: 5 · 2022: 8 · 2021: 4 · 2020: 8 · 2019: 3 · 2018: 5 · 2017: 10 · 2016: 9 · 2015: 8 · 2014: 3 · 2013: 8 · 2012: 12
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Canadian Diabetes Association
- University of Alberta
- Fondation pour la Recherche Médicale
- Alberta Heritage Foundation for Medical Research
- Alberta Diabetes Foundation
- Canadian Institutes of Health Research (MOP86544, MOP-97845)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- SUMOylation, SUMO1, insulin secretion, synaptotagmin VII, SENP1, deSUMOylation, SNARE complex, calcium signaling, glucose-stimulated insulin secretion, pancreatic islets, INS-1 cells
- MeSH terms
- Insulin Secretion, Analysis of Variance, Animals, Calcium, Cells, Cultured, Cysteine Endopeptidases, Exocytosis, Glucose, Humans, Insulin, Microscopy, Electron, Endopeptidases, Blotting, Western, Secretory Vesicles, SUMO-1 Protein, Immunoprecipitation, Insulin-Secreting Cells, Synaptotagmins, Mice, HEK293 Cells, Sumoylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review